Invicta Diagnostic
Invicta Diagnostic
Healthcare ServicesKey Fundamentals
SMEHealthcare Service ProviderHealthcare ServicesTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
1- Though the company is reporting repeated profits, it is not paying out dividend
Growth Rate
Quarterly Results
| Particulars | Sep 2025 | Mar 2026 |
|---|---|---|
| Sales | 16.95 | 15.41 |
| Expenses | 10.19 | 12.42 |
| Operating Profit | 6.76 | 2.99 |
| OPM % | 39.88% | 19.4% |
| Other Income | 0.13 | 0.56 |
| Interest | 0.1 | 0.09 |
| Depreciation | 1.37 | 1.88 |
| PBT | 5.42 | 1.58 |
| Tax % | 24.72% | 50% |
| Net Profit | 4.08 | 0.79 |
| EPS in Rs | 4.32 | 0.72 |
Profit & Loss
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 7.46 | 7.99 | 30.1 | 32.35 |
| Expenses | 4.22 | 4.59 | 20.91 | 22.58 |
| Operating Profit | 3.24 | 3.4 | 9.19 | 9.77 |
| OPM % | 43.43% | 42.55% | 30.53% | 30.2% |
| Other Income | 0 | 0.35 | 0.09 | 0.69 |
| Interest | 0.02 | 0.08 | 0.23 | 0.2 |
| Depreciation | 0.95 | 0.98 | 2.49 | 3.25 |
| PBT | 2.27 | 2.69 | 6.56 | 7.01 |
| Tax % | 22.91% | 0% | 25% | 30.39% |
| Net Profit | 1.76 | 2.69 | 4.93 | 4.88 |
| EPS in Rs | — | 205 | 5.81 | 3.91 |
| Div. Payout % | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | — | 0.13 | 8.42 | 12.57 |
| Reserves | — | 12.05 | 5.18 | 37.35 |
| Borrowings | — | 1.87 | 3.53 | 3.67 |
| Other Liabilities | — | 1.79 | 4.09 | 6.65 |
| Total Liabilities | — | 15.84 | 21.22 | 60.24 |
| Fixed Assets | — | 11.78 | 9.58 | 19.2 |
| CWIP | — | 0 | 0 | 0 |
| Investments | — | 0 | 4.33 | 6.2 |
| Other Assets | — | 4.06 | 7.31 | 34.84 |
| Total Assets | — | 15.84 | 21.22 | 60.24 |
Cash Flow
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating | — | 4.21 | 6.56 | 2.93 |
| Investing | — | -10.01 | -5.23 | -13.67 |
| Financing | — | 7.14 | -0.5 | 30.79 |
| Net Cash Flow | — | 1.34 | 0.83 | 20.05 |
| Free Cash Flow | — | -8.56 | 6.23 | -9.93 |
| CFO/OP | — | 124 | 71 | 40 |
Ratios
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debtor Days | — | 37.46 | 17.7 | 6.43 |
| Inventory Days | — | 297 | 83.33 | 78.88 |
| Days Payable | — | 1,103 | 70 | 254 |
| Cash Conversion Cycle | — | -769 | 31.04 | -169 |
| Working Capital Days | — | 5.94 | 18.55 | 55.74 |
| ROCE % | — | — | 45.04% | 19.43% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Invicta Diagnostic insights
51 extracted metrics + investor summaries across FY23–FY26.
Documents
Frequently Asked Questions about Invicta Diagnostic
What does Invicta Diagnostic Ltd do?
Where is Invicta Diagnostic Ltd (INVICTA) listed?
Which sector does Invicta Diagnostic Ltd belong to?
What is the market capitalisation of Invicta Diagnostic Ltd?
What is the PE ratio of Invicta Diagnostic Ltd?
What is the 52-week high and low of Invicta Diagnostic Ltd?
What is the Return on Equity (ROE) of Invicta Diagnostic Ltd?
Company Information
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions [1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/INVICTA.md for Invicta Diagnostic Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.